Pieris Pharmaceuticals
Founded
2001
2001
Patents
37
37
Clinical Trials
6
6
Publications
11
11
Technologies
Pharmaceutical and Drug DiscoveryPieris Pharmaceuticals is a clinical-stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways in a unique and transformative way. Our pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, inhaled Anticalin proteins to treat respiratory diseases, such as uncontrolled asthma, and a half-life-optimized Anticalin protein to treat anemia.